Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Five SBIR grants awarded to GeneMedicine

Oct. 25, 1996

KS Biomedix-Roche antibody collaboration

Oct. 25, 1996

Medarex receives federal funding for Bispecific technology

Oct. 25, 1996

ImmunoGen's antibody humanization technology reported to be superior to conventional methods

Oct. 25, 1996

Megabios in vivo gene delivery systems available for licensing

Oct. 25, 1996

Pharmacopeia receives patent coverage for drug discovery technology

Oct. 25, 1996

P&U reports compounds for improving drug bioavailability

Oct. 25, 1996

Funding for Genetronics' electroporation delivery technology

Oct. 18, 1996

Regeneron-Pharmacopeia drug discovery collaboration

Oct. 18, 1996

Peptidomimetic compounds disclosed by University of Pennsylvania

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...